hydrocodone bitartrate extended release capsules

Firm Zogenix Entered Into a Development and Option Agreement (D&O Agreement) with Altus
Nov 6, 2013
US-based pharmaceutical firm Zogenix has entered into a development and option agreement (D&O Agreement) with Altus Formulation (Altus) to develop abuse deterrent formulations of Zohydro ER (hydrocodone bitartrate) extended-release ...

Tags: Zogenix, Zohydro ER
Zogenix Has Announced That The US FDA Has Approved Zohydro ER Extended-Release Capsules.
Oct 30, 2013
Pharmaceutical companyc Food and Drug Administration (FDA) has approved Zohydro ER (hydrocodone bitartrate) extended-release capsules. Zohydro ER is an opioid agonist, extended-release oral formulation of hydrocodone without ...

Tags: Health, Medicine
FDA Accepted The Review of Zogenix NDA for Zohydro ER
Dec 5, 2012
The FDA has accepted the review of Zogenix new drug application (NDA) for Zohydro ER (hydrocodone bitartrate extended-release capsules) for the treatment of moderate to severe chronic pain. Zohydro ER is an oral, single-entity (without ...

Tags: Zohydro ER, hydrocodone bitartrate extended-release capsules